{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:29:54Z","timestamp":1792013394773,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jid.2017.03.041","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T19:01:43Z","timestamp":1498158103000},"page":"2101-2109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways"],"prefix":"10.1016","volume":"137","author":[{"given":"Ji-Ae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-Ki","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Wook","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok Sarah","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.03.041_bib1","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/jid.2015.317","article-title":"IFNlambda Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism","volume":"135","author":"Alase","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.03.041_bib2","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in\u00a0vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J\u00a0Virol"},{"issue":"5","key":"10.1016\/j.jid.2017.03.041_bib3","doi-asserted-by":"crossref","first-page":"G960","DOI":"10.1152\/ajpgi.00126.2005","article-title":"IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression","volume":"289","author":"Brand","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jid.2017.03.041_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cell.2011.09.022","article-title":"Activation of STAT6 by STING is critical for antiviral innate immunity","volume":"147","author":"Chen","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.03.041_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.onc.1201206","article-title":"Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma","volume":"15","author":"DeYoung","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.03.041_bib6","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1128\/JVI.03370-13","article-title":"Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens","volume":"88","author":"Gack","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2017.03.041_bib7","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1086\/342963","article-title":"Varicella-zoster virus: atypical presentations and unusual complications","volume":"186","author":"Gnann","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jid.2017.03.041_bib8","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.69.11.7367-7370.1995","article-title":"The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22","volume":"69","author":"Heineman","year":"1995","journal-title":"J\u00a0Virol"},{"issue":"7213","key":"10.1016\/j.jid.2017.03.041_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"issue":"7265","key":"10.1016\/j.jid.2017.03.041_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jid.2017.03.041_bib11","doi-asserted-by":"crossref","first-page":"e1003896","DOI":"10.1371\/journal.ppat.1003896","article-title":"RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jid.2017.03.041_bib12","doi-asserted-by":"crossref","first-page":"35324","DOI":"10.18632\/oncotarget.6117","article-title":"Insights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2017.03.041_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4110\/in.2016.16.5.286","article-title":"Enhanced viral replication by cellular replicative senescence","volume":"16","author":"Kim","year":"2016","journal-title":"Immune Netw"},{"key":"10.1016\/j.jid.2017.03.041_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2017.03.041_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","article-title":"The cGAS-STING defense pathway and its counteraction by viruses","volume":"19","author":"Ma","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jid.2017.03.041_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/viro.2002.1556","article-title":"The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells","volume":"304","author":"Mo","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jid.2017.03.041_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ni.2915","article-title":"Diverse intracellular pathogens activate type III interferon expression from peroxisomes","volume":"15","author":"Odendall","year":"2014","journal-title":"Nature Immunol"},{"key":"10.1016\/j.jid.2017.03.041_bib18","first-page":"633","article-title":"Prevention of shingles: safety and efficacy of live zoster vaccine","volume":"3","author":"Quan","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jid.2017.03.041_bib19","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2017.03.041_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/mi.2015.124","article-title":"A\u00a0STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin","volume":"9","author":"Royer","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jid.2017.03.041_bib21","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1128\/JVI.01147-10","article-title":"Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses","volume":"84","author":"Sen","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2017.03.041_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2017.03.041_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2006.10.027","article-title":"Safety and tolerability of a high-potency zoster vaccine in adults >\/= 50 or years of age","volume":"25","author":"Tyring","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jid.2017.03.041_bib24","doi-asserted-by":"crossref","first-page":"e16870","DOI":"10.1371\/journal.pone.0016870","article-title":"The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3","volume":"6","author":"Vandevenne","year":"2011","journal-title":"PloS One"},{"issue":"Suppl. 1","key":"10.1016\/j.jid.2017.03.041_bib25","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/infdis\/166.Supplement_1.S51","article-title":"Therapeutic approaches to varicella-zoster virus infections","volume":"166","author":"Whitley","year":"1992","journal-title":"J\u00a0Infect Dis"},{"issue":"204","key":"10.1016\/j.jid.2017.03.041_bib26","doi-asserted-by":"crossref","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","article-title":"IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral\u00a0competence in psoriasis","volume":"5","author":"Wolk","year":"2013","journal-title":"Science Transl Med"},{"key":"10.1016\/j.jid.2017.03.041_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4167\/jbv.2014.44.4.326","article-title":"Characterization of the repeat sequences of varicella-zoster virus","volume":"44","author":"Won","year":"2014","journal-title":"J\u00a0Bacteriol Virol"},{"key":"10.1016\/j.jid.2017.03.041_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.03.041_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrmicro3215","article-title":"Molecular mechanisms of varicella zoster virus pathogenesis","volume":"12","author":"Zerboni","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jid.2017.03.041_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol Cell"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17316603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17316603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T18:13:27Z","timestamp":1602353607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17316603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0022202X17316603"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.03.041","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}